Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dr Reddys Laboratories (RDY) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for Dr Reddys Laboratories (RDY) over the last 17 years, with Q4 2025 value amounting to $548314.8.

  • Dr Reddys Laboratories' Shares Outstanding (Weighted Average) fell 503.4% to $548314.8 in Q4 2025 from the same period last year, while for Dec 2025 it was $548314.8, marking a year-over-year decrease of 503.4%. This contributed to the annual value of $3.4 million for FY2023, which is N/A changed from last year.
  • As of Q4 2025, Dr Reddys Laboratories' Shares Outstanding (Weighted Average) stood at $548314.8, which was down 503.4% from $393144.8 recorded in Q3 2025.
  • Over the past 5 years, Dr Reddys Laboratories' Shares Outstanding (Weighted Average) peaked at $3.3 million during Q1 2023, and registered a low of $199107.5 during Q2 2025.
  • For the 5-year period, Dr Reddys Laboratories' Shares Outstanding (Weighted Average) averaged around $1.2 million, with its median value being $928021.2 (2022).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 9868.88% in 2022, then plummeted by 8190.13% in 2024.
  • Dr Reddys Laboratories' Shares Outstanding (Weighted Average) (Quarter) stood at $1.8 million in 2021, then soared by 42.53% to $2.6 million in 2022, then plummeted by 76.36% to $615267.0 in 2023, then fell by 6.16% to $577379.9 in 2024, then dropped by 5.03% to $548314.8 in 2025.
  • Its last three reported values are $548314.8 in Q4 2025, $393144.8 for Q3 2025, and $199107.5 during Q2 2025.